Vivaglobin Approved - ZLB Behring - Treatment for Primary Immunodeficiencies
Vivaglobin is a subcutaneous immunoglobulin (Ig) replacement therapy for treating patients with primary immunodeficiencies (PI).Posted: January 2006
Vivaglobin (immune globulin subcutaneous (human)) FDA Approval History

